Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aiach

Showing results (181-190 of 236) with videos related to

Pageof 24
Sort By:
Annales De Medecine Interne|January 1, 1979
[Use of urokinase during surgery: a new approach to the treatment of vascular obliterative disease (author's transl)]J N Fiessinger, M Vayssairat, Y Juillet, et al.
Annales De Medecine Interne|January 1, 1986
[Treatment with the urokinase-lysyl plasminogen combination of developmental outbreaks of arteriopathies]J F Vitoux, M Roncato, J M Pernes, et al.
Thrombosis and Haemostasis|December 2, 1991
Antithrombin III: a database of mutationsD A Lane, H Ireland, R J Olds, et al.
Haemostasis|January 1, 1986
Thrombolytic treatment in obliterative arterial disease. Can thrombolytic agents compete with surgery?J N Fiessinger, M Aiach, J F Vitoux, et al.
Haemostasis|January 1, 1986
[Thrombolytic treatment of arteriopathies. Do thrombolytics compete with surgery?]J N Fiessinger, M Aiach, J F Vitoux, et al.
Dermatologica|January 1, 1986
Von Recklinghausen neurofibromatosis and hereditary plasminogen deficiencyP Priollet, M Roncato, M Vayssairat, et al.
The Journal of Clinical Investigation|October 1, 1989
Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutationP Molho-Sabatier, M Aiach, I Gaillard, et al.
Blood|July 1, 1993
Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activityS Gandrille, M Alhenc-Gelas, P Gaussem, et al.
Thrombosis and Haemostasis|June 1, 1994
Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study GroupM Alhenc-Gelas, C Jestin-Le Guernic, J F Vitoux, et al.
British Journal of Haematology|June 1, 1997
Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndromeD Lasne, R Saffroy, C Bachelot, et al.
Pageof 24

Showing results (181-190 of 236) with videos related to

Sort By:
Pageof 24
Annales De Medecine Interne|January 1, 1979
[Use of urokinase during surgery: a new approach to the treatment of vascular obliterative disease (author's transl)]J N Fiessinger, M Vayssairat, Y Juillet, et al.
Annales De Medecine Interne|January 1, 1986
[Treatment with the urokinase-lysyl plasminogen combination of developmental outbreaks of arteriopathies]J F Vitoux, M Roncato, J M Pernes, et al.
Thrombosis and Haemostasis|December 2, 1991
Antithrombin III: a database of mutationsD A Lane, H Ireland, R J Olds, et al.
Haemostasis|January 1, 1986
Thrombolytic treatment in obliterative arterial disease. Can thrombolytic agents compete with surgery?J N Fiessinger, M Aiach, J F Vitoux, et al.
Haemostasis|January 1, 1986
[Thrombolytic treatment of arteriopathies. Do thrombolytics compete with surgery?]J N Fiessinger, M Aiach, J F Vitoux, et al.
Dermatologica|January 1, 1986
Von Recklinghausen neurofibromatosis and hereditary plasminogen deficiencyP Priollet, M Roncato, M Vayssairat, et al.
The Journal of Clinical Investigation|October 1, 1989
Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutationP Molho-Sabatier, M Aiach, I Gaillard, et al.
Blood|July 1, 1993
Five novel mutations located in exons III and IX of the protein C gene in patients presenting with defective protein C anticoagulant activityS Gandrille, M Alhenc-Gelas, P Gaussem, et al.
Thrombosis and Haemostasis|June 1, 1994
Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study GroupM Alhenc-Gelas, C Jestin-Le Guernic, J F Vitoux, et al.
British Journal of Haematology|June 1, 1997
Tests for heparin-induced thrombocytopenia in primary antiphospholipid syndromeD Lasne, R Saffroy, C Bachelot, et al.
Pageof 24